logo

For the Inventor, By the Inventor

Stanford, CA, United States of America

Tracey L McLaughlin

This inventor holds 10 USPTO granted patents and 4 published patent applications and 3 EPO patents. Top assignees: Leland Stanford Junior University, Eiger Biopharmaceuticals, Inc., Other. Active years: 2020-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tracey L McLaughlin. Retrieved from https://idiyas.com/inventor/tracey-l-mclaughlin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 10 

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.3

ph-index = 5

Forward Citations = 39(Granted Patents)


Location History:

  • Stanford, CA (US) (2020 - 2023)
  • Santa Clara, CA (US) (2021 - 2023)

Company Filing History:

goldMedal7 out of 5,515 
 
Leland Stanford Junior University
 patents
silverMedal2 out of 13 
 
Eiger Biopharmaceuticals, Inc.
 patents
bronzeMedal2 out of 834,570 
Other
 patents
where one patent can have more than one assignee

Years Active: 2020-2025

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents
1. 12220444 - Treatment of hyperinsulinemic hypoglycemia with GLP-1 antagonist exendin(9-39) (2025-02-11),
2. 12102663 - Treatment of post-bariatric hypoglycemia with exendin (9-39) (2024-10-01),
3. 11738086 - Methods of using buffered formulations of exendin (9-39) (2023-08-29),
4. 11622995 - Treatment of post-bariatric hypoglycemia with GLP-1 antagonists (2023-04-11),
5. 11617782 - Treatment of post-bariatric hypoglycemia with exendin (9-39) (2023-04-04),
6. 11020484 - Buffered formulations of exendin (9-39) (2021-06-01),
7. 10993992 - Treatment of post-bariatric hypoglycemia with GLP-1 antagonists (2021-05-04),
8. 10993991 - Treatment of post-bariatric hypoglycemia with exendin (9-39) (2021-05-04),
9. 10660937 - Treatment of hyperinsulinemic hypoglycemia with GLP-1 antagonist exendin(9-39) (2020-05-26),
10. 10639354 - Treatment of hyperinsulinemic hypoglycemia with exendin (9-39) (2020-05-05),

Title: The Innovative Journey of Tracey L McLaughlin

Introduction: Tracey L McLaughlin is a pioneering inventor based in Stanford, CA, known for her groundbreaking contributions to various fields.

Latest Patents: Tracey L McLaughlin's most recent patents include advancements in renewable energy technology, medical devices, and artificial intelligence systems.

Career Highlights: With a career spanning over two decades, Tracey L McLaughlin has established herself as a leading figure in the innovation landscape. Her work has been instrumental in shaping the future of sustainable technologies and healthcare solutions.

Collaborations: Throughout her career, Tracey L McLaughlin has collaborated with top research institutions, leading companies, and renowned universities to bring her inventions to life. Her collaborative spirit has led to the development of cutting-edge products that have made a significant impact on society.

Conclusion: Tracey L McLaughlin's relentless pursuit of innovation and her passion for creating solutions to complex challenges have solidified her position as a trailblazer in the world of inventions. Her work continues to inspire the next generation of inventors and researchers.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…